SK Biopharmaceuticals Co. Ltd. has launched a central nervous system-focused biotech company called Ignis Therapeutics Ltd. with a $180 million series A round led by 6 Dimensions Capital L.P. The ...
The Ignis may be small, but it has a surprising amount of character. It may be light on its feet with its 1.2-litre petrol engine and stature, but it is one of the liveliest hatchbacks in town. The ...